WHY CHOOSE US
The
The
NeoBiotechnologies
Difference:
Unparalleled Monospecificity Ensured by the Most Rigorous Validation
Free Shipping in the U.S. for orders over $1000. Shop Now>>
Unparalleled Monospecificity Ensured by the Most Rigorous Validation
At NeoBiotechnologies, we understand the importance of precise and targeted research antibodies. Our antibodies are developed with unparalleled specificity, enabling them to selectively recognize and bind to cancer-specific markers. Less than 2% of our antibodies pass our criteria for commercial production. Our antibodies undergo multiple validation techniques, including the HuProt™ Protein Array which tests for specificity against 21,000 full-length proteins. With NeoBiotechnologies’ antibodies, researchers can confidently perform their assays and unravel new insights into disease mechanisms while pathologists can be confident about the diagnoses they make.
NeoBiotechnologies’ extensive portfolio of over 10,000 unique antibody products, against a wide range of the human proteome and available in over 15,000 formulations, offers researchers an expansive range of protein targeting opportunities. Our monospecific antibodies cover a range of research areas and disease states, including cancer / oncology, immunology, metabolism, neuroscience, and many more. With NeoBiotechnologies’ antibodies, researchers can explore new avenues from basic research to precision medicine.
Collaboration is at the heart of scientific progress, and NeoBiotechnologies is committed to fostering partnerships with esteemed researchers and institutions worldwide. By actively engaging in collaborative research projects, we ensure that our antibodies are rigorously tested and optimized, pushing the boundaries of research across disciplines. Together, we can unlock new breakthroughs, accelerate discoveries, and provide pathologists with tools to make a meaningful impact on patients’ lives.
